METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA

METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA was reported 11052 times

METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TRANSFERRIN DECREASED 43 0.2098
1 VENTRICULAR HYPERKINESIA 13 0.1461
2 AGONAL RESPIRATION 32 0.1131
3 ANTI-ERYTHROPOIETIN ANTIBODY 3 0.1111
4 SHUNT STENOSIS 27 0.0975
5 NEONATAL HYPOCALCAEMIA 6 0.0800
6 APLASIA PURE RED CELL 264 0.0767
7 SHUNT OCCLUSION 34 0.0669
8 RIGHT ATRIAL ENLARGEMENT 13 0.0657
9 HYPOCHROMASIA 13 0.0647
10 RETICULOCYTE COUNT DECREASED 26 0.0603
11 ANTI-ERYTHROPOIETIN ANTIBODY POSITIVE 14 0.0558
12 LEFT VENTRICULAR ENLARGEMENT 13 0.0510
13 ERYTHROBLAST COUNT INCREASED 3 0.0500
14 TRANSFERRIN SATURATION DECREASED 19 0.0445
15 MITRAL VALVE THICKENING 13 0.0436
16 SHUNT THROMBOSIS 4 0.0404
17 INGUINAL HERNIA, OBSTRUCTIVE 3 0.0375
18 MARASMUS 56 0.0368
19 GRAFT HAEMORRHAGE 3 0.0349
20 TRANSFERRIN SATURATION INCREASED 11 0.0320
21 BLOOD ERYTHROPOIETIN INCREASED 3 0.0303
22 REFRACTORY CYTOPENIA WITH UNILINEAGE DYSPLASIA 6 0.0303
23 LEFT ATRIAL ENLARGEMENT 13 0.0241
24 DOSING ERROR 4 0.0238
25 ZINC DEFICIENCY 5 0.0233
26 MEAN PLATELET VOLUME INCREASED 14 0.0232
27 HAEMOGLOBIN INCREASED 104 0.0228
28 DIALYSIS RELATED COMPLICATION 8 0.0226
29 PULSE ABSENT 106 0.0223
30 ARTERIOVENOUS FISTULA SITE HAEMORRHAGE 4 0.0214
31 SEIZURE LIKE PHENOMENA 34 0.0200
32 RENAL CYST INFECTION 3 0.0189
33 SERUM FERRITIN INCREASED 94 0.0178
34 SHUNT INFECTION 4 0.0176
35 ARTERIOVENOUS FISTULA OCCLUSION 3 0.0171
36 BLOOD PHOSPHORUS INCREASED 44 0.0161
37 RECTAL ULCER HAEMORRHAGE 4 0.0160
38 MYELOCYTE COUNT INCREASED 3 0.0160
39 PYELONEPHRITIS CHRONIC 3 0.0160
40 HYPERTENSIVE ENCEPHALOPATHY 9 0.0152
41 CARBON DIOXIDE DECREASED 17 0.0148
42 ANAEMIA NEONATAL 7 0.0145
43 VARICOSE ULCERATION 4 0.0145
44 ARTERIOVENOUS FISTULA THROMBOSIS 5 0.0145
45 SJS-TEN OVERLAP 10 0.0142
46 IMMATURE GRANULOCYTE COUNT INCREASED 4 0.0141
47 DIABETIC GANGRENE 4 0.0141
48 UNRESPONSIVE TO STIMULI 356 0.0138
49 ALLERGIC TRANSFUSION REACTION 2 0.0132
50 BLOOD BICARBONATE DECREASED 25 0.0132
51 BLOOD PARATHYROID HORMONE INCREASED 37 0.0127
52 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT 10 0.0122
53 ARTERIOVENOUS FISTULA OPERATION 3 0.0111
54 SHUNT MALFUNCTION 3 0.0106
55 NEPHROGENIC ANAEMIA 49 0.0106
56 URETERIC CANCER 4 0.0100
57 ERYTHROPOIESIS ABNORMAL 3 0.0098
58 PERITONEAL DIALYSIS 8 0.0097
59 GASTRIC ANTRAL VASCULAR ECTASIA 5 0.0095
60 BLOOD CHLORIDE INCREASED 16 0.0093
61 HYPERCREATINAEMIA 3 0.0091
62 BRONCHOPULMONARY DYSPLASIA 7 0.0087
63 FAT EMBOLISM 3 0.0085
64 ARTERIOVENOUS FISTULA SITE COMPLICATION 5 0.0083
65 GLOBULINS INCREASED 3 0.0082
66 MONOCYTOSIS 5 0.0081
67 VIRAL MYOCARDITIS 3 0.0080
68 VASCULAR GRAFT OCCLUSION 3 0.0078
69 FOLATE DEFICIENCY 9 0.0078
70 ANISOCYTOSIS 5 0.0076
71 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 8 0.0075
72 ACOUSTIC NEUROMA 3 0.0073
73 BLOOD IRON DECREASED 83 0.0070
74 HYPERTENSIVE HEART DISEASE 13 0.0069
75 HIGH DENSITY LIPOPROTEIN DECREASED 23 0.0069
76 THALAMUS HAEMORRHAGE 6 0.0069
77 AZOTAEMIA 27 0.0068
78 DIAPHRAGMATIC PARALYSIS 4 0.0067
79 ANAL SQUAMOUS CELL CARCINOMA 2 0.0065
80 RED CELL DISTRIBUTION WIDTH INCREASED 27 0.0065
81 FOAMING AT MOUTH 13 0.0064
82 NORMOCHROMIC NORMOCYTIC ANAEMIA 19 0.0063
83 POLYCYTHAEMIA 13 0.0063
84 PARATHYROIDECTOMY 3 0.0062
85 MOANING 7 0.0062
86 ANION GAP INCREASED 8 0.0060
87 ELECTROCARDIOGRAM T WAVE INVERSION 13 0.0059
88 POSTURING 3 0.0058
89 HAEMOGLOBIN DECREASED 587 0.0057
90 RENAL FAILURE CHRONIC 43 0.0056
91 FEELING HOT 341 0.0056
92 ANEURYSM RUPTURED 5 0.0055
93 BLOOD UREA INCREASED 90 0.0054
94 DIALYSIS 76 0.0054
95 APNOEIC ATTACK 3 0.0053
96 HYPERPARATHYROIDISM SECONDARY 13 0.0052
97 ACUTE PULMONARY OEDEMA 29 0.0052
98 PROCALCITONIN INCREASED 6 0.0051
99 FLUSHING 515 0.0051
100 VITAMIN B12 INCREASED 4 0.0050
101 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 8 0.0048
102 PROCEDURAL HYPOTENSION 4 0.0047
103 HYPERPHOSPHATAEMIA 10 0.0046
104 SERUM FERRITIN DECREASED 8 0.0046
105 PULSE ABNORMAL 11 0.0046
106 ANAEMIA MEGALOBLASTIC 2 0.0045
107 AORTIC VALVE STENOSIS 8 0.0045
108 MITRAL VALVE STENOSIS 3 0.0045
109 HYPERVOLAEMIA 22 0.0044
110 HYPOGLYCAEMIC SEIZURE 4 0.0044
111 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 18 0.0044
112 METHAEMOGLOBINAEMIA 10 0.0043
113 ANAPHYLACTOID SHOCK 2 0.0043
114 HYPORESPONSIVE TO STIMULI 5 0.0043
115 DIASTOLIC DYSFUNCTION 13 0.0042
116 ALANINE AMINOTRANSFERASE DECREASED 3 0.0041
117 NORMOCYTIC ANAEMIA 6 0.0041
118 BLOOD ALBUMIN DECREASED 32 0.0040
119 HYPOCHROMIC ANAEMIA 4 0.0039
120 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 13 0.0039
121 SUBCUTANEOUS HAEMATOMA 5 0.0039
122 MEAN CELL VOLUME INCREASED 10 0.0039
123 BLOOD PRESSURE SYSTOLIC DECREASED 17 0.0037
124 BLOOD IRON INCREASED 7 0.0037
125 RETICULOCYTE COUNT INCREASED 3 0.0037
126 ENTEROCOCCAL SEPSIS 3 0.0037
127 MYELODYSPLASTIC SYNDROME 53 0.0037
128 DIABETIC NEPHROPATHY 8 0.0036
129 RENAL TRANSPLANT 13 0.0036
130 DIVERTICULUM INTESTINAL HAEMORRHAGIC 8 0.0036
131 CONGENITAL CYSTIC KIDNEY DISEASE 3 0.0035
132 AORTIC VALVE INCOMPETENCE 15 0.0035
133 CARDIAC FAILURE CHRONIC 15 0.0035
134 LEFT VENTRICULAR HYPERTROPHY 15 0.0035
135 MALIGNANT HYPERTENSION 3 0.0035
136 TONGUE PRURITUS 3 0.0035
137 HAEMATOCRIT DECREASED 69 0.0035
138 ACUTE PRERENAL FAILURE 4 0.0035
139 HYPOPNOEA 12 0.0035
140 AORTIC STENOSIS 12 0.0034
141 EXTREMITY NECROSIS 6 0.0034
142 VASCULAR DEMENTIA 3 0.0034
143 BLOOD CALCIUM DECREASED 38 0.0034
144 EOSINOPHIL COUNT INCREASED 28 0.0034
145 PARVOVIRUS B19 INFECTION 3 0.0034
146 UPPER RESPIRATORY TRACT INFLAMMATION 4 0.0033
147 TRAUMATIC INTRACRANIAL HAEMORRHAGE 3 0.0033
148 MEAN CELL VOLUME DECREASED 5 0.0032
149 BLOOD CHOLESTEROL DECREASED 6 0.0032
150 AMPUTATION 4 0.0032
151 LIP DISCOLOURATION 4 0.0032
152 TROPONIN T INCREASED 4 0.0032
153 MALLORY-WEISS SYNDROME 4 0.0031
154 HEPATIC INFECTION 4 0.0031
155 LEFT VENTRICULAR DYSFUNCTION 21 0.0031
156 BLOOD URIC ACID INCREASED 18 0.0031
157 BLOOD CHLORIDE DECREASED 8 0.0031
158 BLOOD IRON ABNORMAL 3 0.0031
159 OCCULT BLOOD POSITIVE 6 0.0031
160 MONOCYTE COUNT INCREASED 11 0.0030
161 HAEMOLYSIS 23 0.0030
162 BLOOD PRESSURE DECREASED 190 0.0029
163 HAEMODIALYSIS 24 0.0029
164 OEDEMA MUCOSAL 3 0.0029
165 POLYOMAVIRUS VIRAEMIA 3 0.0028
166 CYTOMEGALOVIRUS TEST POSITIVE 5 0.0028
167 IRON OVERLOAD 3 0.0028
168 CLAUSTROPHOBIA 3 0.0027
169 FOOT AMPUTATION 4 0.0027
170 CALCIPHYLAXIS 5 0.0027
171 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 9 0.0027
172 NEPHROSCLEROSIS 3 0.0027
173 KLEBSIELLA SEPSIS 3 0.0027
174 ARTERIAL HAEMORRHAGE 3 0.0026
175 DIABETIC FOOT 8 0.0026
176 PELVIC ABSCESS 3 0.0026
177 BLOOD PRESSURE IMMEASURABLE 4 0.0026
178 RECTAL ULCER 3 0.0026
179 TRANSPLANT 6 0.0025
180 BILE DUCT CANCER 3 0.0025
181 INTRA-ABDOMINAL HAEMORRHAGE 6 0.0025
182 HYPERTENSIVE CRISIS 28 0.0025
183 BILE DUCT STONE 8 0.0025
184 HAEMOGLOBIN ABNORMAL 16 0.0025
185 END STAGE RENAL DISEASE 45 0.0025
186 SKULL FRACTURE 4 0.0025
187 SUDDEN DEATH 26 0.0025
188 INJECTION RELATED REACTION 4 0.0024
189 ANAEMIA HAEMOLYTIC AUTOIMMUNE 2 0.0024
190 PERITONITIS BACTERIAL 24 0.0024
191 THROAT TIGHTNESS 64 0.0024
192 CARDIO-RESPIRATORY ARREST 98 0.0023
193 ANAEMIA MACROCYTIC 5 0.0023
194 FEMORAL NECK FRACTURE 12 0.0023
195 BLOOD POTASSIUM INCREASED 38 0.0023
196 GANGRENE 14 0.0023
197 DERMATITIS EXFOLIATIVE GENERALISED 8 0.0023
198 ANAEMIA POSTOPERATIVE 3 0.0023
199 PSEUDOMONAL SEPSIS 4 0.0023
200 PACKED RED BLOOD CELL TRANSFUSION 3 0.0023
201 NEONATAL RESPIRATORY DISTRESS SYNDROME 8 0.0023
202 PSEUDOMEMBRANOUS COLITIS 5 0.0022
203 HYPERURICAEMIA 9 0.0022
204 BLOOD PHOSPHORUS DECREASED 8 0.0022
205 PERITONEAL CLOUDY EFFLUENT 3 0.0022
206 RENAL ARTERY STENOSIS 3 0.0022
207 PALLOR 59 0.0022
208 CARDIAC FAILURE 174 0.0022
209 GASTRIC ULCER HAEMORRHAGE 12 0.0022
210 GLOMERULAR FILTRATION RATE DECREASED 26 0.0021
211 HYPOCALCAEMIA 40 0.0021
212 CARDIAC FAILURE ACUTE 14 0.0021
213 LACUNAR INFARCTION 5 0.0021
214 PERITONITIS 43 0.0021
215 PNEUMONIA CYTOMEGALOVIRAL 4 0.0021
216 IRON DEFICIENCY ANAEMIA 19 0.0021
217 GASTROINTESTINAL NECROSIS 6 0.0021
218 SUDDEN CARDIAC DEATH 7 0.0021
219 PYELONEPHRITIS ACUTE 4 0.0020
220 PRURITUS 783 0.0020
221 HEART VALVE REPLACEMENT 3 0.0020
222 NEPHRECTOMY 3 0.0020
223 DYSPNOEA 1139 0.0020
224 GASTRITIS HAEMORRHAGIC 3 0.0020
225 JAUNDICE CHOLESTATIC 7 0.0020
226 FUNGAL PERITONITIS 3 0.0020
227 RENAL HAEMORRHAGE 4 0.0020
228 DEVICE RELATED INFECTION 30 0.0019
229 VENOUS THROMBOSIS LIMB 4 0.0019
230 HYPERTROPHIC CARDIOMYOPATHY 3 0.0019
231 CYANOSIS 30 0.0019
232 EYE MOVEMENT DISORDER 13 0.0019
233 PRURITUS GENERALISED 41 0.0019
234 TRICUSPID VALVE INCOMPETENCE 15 0.0019
235 CEREBRAL INFARCTION 46 0.0019
236 ANGINA UNSTABLE 12 0.0018
237 HAEMORRHOIDAL HAEMORRHAGE 9 0.0018
238 DEATH 1583 0.0018
239 ACUTE MYOCARDIAL INFARCTION 54 0.0018
240 VASOPLEGIA SYNDROME 3 0.0018
241 ANAEMIA 347 0.0018
242 CARDIAC ARREST 150 0.0018
243 RESPIRATORY DISTRESS 50 0.0018
244 RESUSCITATION 3 0.0018
245 TROPONIN I INCREASED 3 0.0018
246 APNOEA 14 0.0018
247 PARESIS 4 0.0018
248 MALIGNANT PLEURAL EFFUSION 3 0.0018
249 IRON DEFICIENCY 8 0.0018
250 BLOOD CREATININE INCREASED 116 0.0018
251 CEREBELLAR INFARCTION 3 0.0018
252 BACTERAEMIA 21 0.0018
253 HYPERKALAEMIA 62 0.0018
254 ENTERITIS INFECTIOUS 3 0.0018
255 HAEMATOCRIT INCREASED 4 0.0018
256 NO ADVERSE EVENT 316 0.0017
257 CYTOMEGALOVIRUS COLITIS 4 0.0017
258 SPONDYLOLISTHESIS 3 0.0017
259 FLUID OVERLOAD 25 0.0017
260 RED BLOOD CELL COUNT DECREASED 49 0.0017
261 EAR PRURITUS 6 0.0017
262 PULSELESS ELECTRICAL ACTIVITY 7 0.0017
263 MYOCARDIAL ISCHAEMIA 19 0.0017
264 CEREBROVASCULAR DISORDER 5 0.0017
265 MEAN CELL HAEMOGLOBIN DECREASED 3 0.0016
266 SINUS NODE DYSFUNCTION 3 0.0016
267 MELAENA 36 0.0016
268 GLOMERULONEPHRITIS 4 0.0016
269 STAPHYLOCOCCAL SEPSIS 8 0.0016
270 INTRAVENTRICULAR HAEMORRHAGE 4 0.0016
271 DIVERTICULUM INTESTINAL 7 0.0016
272 INTERVERTEBRAL DISCITIS 3 0.0016
273 CATHETER SITE INFECTION 6 0.0016
274 METASTASES TO PERITONEUM 4 0.0016
275 BONE MARROW FAILURE 32 0.0016
276 ARTERIAL DISORDER 3 0.0016
277 APLASTIC ANAEMIA 8 0.0015
278 MULTI-ORGAN DISORDER 3 0.0015
279 HYPERHIDROSIS 196 0.0015
280 EXFOLIATIVE RASH 4 0.0015
281 ANAPHYLACTIC REACTION 83 0.0015
282 SUDDEN HEARING LOSS 3 0.0015
283 PERIPHERAL ISCHAEMIA 6 0.0015
284 NEUTROPHIL COUNT INCREASED 15 0.0015
285 BRONCHOPNEUMONIA 5 0.0015
286 LEG AMPUTATION 6 0.0015
287 VOMITING 684 0.0015
288 RED BLOOD CELL COUNT INCREASED 4 0.0014
289 VITREOUS HAEMORRHAGE 4 0.0014
290 MULTI-ORGAN FAILURE 25 0.0014
291 LARGE INTESTINE POLYP 10 0.0014
292 RENAL IMPAIRMENT 121 0.0014
293 CHEST DISCOMFORT 146 0.0014
294 DEVICE CONNECTION ISSUE 3 0.0014
295 ANTIPSYCHOTIC DRUG LEVEL INCREASED 4 0.0014
296 EAR SWELLING 3 0.0014
297 RESPIRATORY ARREST 39 0.0014
298 MITRAL VALVE INCOMPETENCE 16 0.0014
299 HYPOTENSION 283 0.0014
300 OESOPHAGEAL VARICES HAEMORRHAGE 3 0.0014
301 HYPERVENTILATION 8 0.0014
302 ESCHERICHIA SEPSIS 4 0.0014
303 FRACTURE 26 0.0014
304 CHEST PAIN 254 0.0014
305 LOSS OF CONSCIOUSNESS 175 0.0014
306 ENDOCARDITIS 7 0.0014
307 RETROPERITONEAL HAEMATOMA 3 0.0014
308 BLOOD PRESSURE INCREASED 206 0.0013
309 LARGE INTESTINAL HAEMORRHAGE 3 0.0013
310 COLITIS ISCHAEMIC 9 0.0013
311 GASTRIC POLYPS 3 0.0013
312 PROTEIN TOTAL DECREASED 5 0.0013
313 SNORING 5 0.0013
314 NEPHROTIC SYNDROME 9 0.0013
315 PNEUMONIA BACTERIAL 12 0.0013
316 LYMPHOCYTE COUNT DECREASED 23 0.0013
317 UROSEPSIS 12 0.0013
318 BLOOD PRESSURE DIASTOLIC INCREASED 6 0.0013
319 DRUG ERUPTION 23 0.0013
320 CHRONIC KIDNEY DISEASE 98 0.0013
321 URTICARIA 216 0.0013
322 VITAMIN D DECREASED 11 0.0013
323 COLON CANCER 19 0.0013
324 C-REACTIVE PROTEIN INCREASED 46 0.0013
325 EOSINOPHILIA 22 0.0013
326 RADIUS FRACTURE 3 0.0012
327 PURPURA 11 0.0012
328 HEART RATE INCREASED 123 0.0012
329 NEUTROPHILIA 7 0.0012
330 CEREBRAL HAEMORRHAGE 44 0.0012
331 ARRHYTHMIA 58 0.0012
332 HYPERTENSION 259 0.0012
333 HYPERCALCAEMIA 15 0.0012
334 ENTEROCOLITIS 7 0.0012
335 AORTIC DISSECTION 5 0.0012
336 ACUTE CORONARY SYNDROME 10 0.0012
337 TOXIC SKIN ERUPTION 12 0.0012
338 UPPER GASTROINTESTINAL HAEMORRHAGE 20 0.0012
339 SUPRAVENTRICULAR EXTRASYSTOLES 4 0.0012
340 BACK PAIN 274 0.0012
341 DIABETIC COMPLICATION 3 0.0012
342 HEPATIC CYST 4 0.0012
343 RED BLOOD CELL SEDIMENTATION RATE INCREASED 13 0.0012
344 BLOOD SODIUM DECREASED 22 0.0012
345 PNEUMONIA ASPIRATION 29 0.0012
346 HYPOALBUMINAEMIA 9 0.0012
347 HEPATIC LESION 5 0.0012
348 CAROTID ARTERY STENOSIS 4 0.0011
349 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 3 0.0011
350 ERYTHEMA 235 0.0011
351 POST PROCEDURAL HAEMORRHAGE 13 0.0011
352 CIRCULATORY COLLAPSE 19 0.0011
353 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 201 0.0011
354 RENAL FAILURE 148 0.0011
355 DECUBITUS ULCER 9 0.0011
356 SEPSIS 123 0.0011
357 THROMBOCYTOSIS 4 0.0011
358 SPINAL COMPRESSION FRACTURE 9 0.0011
359 ANGINA PECTORIS 31 0.0011
360 COLD SWEAT 19 0.0011
361 PULMONARY OEDEMA 48 0.0011
362 GENERALISED ERYTHEMA 6 0.0011
363 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 75 0.0011
364 PRE-ECLAMPSIA 5 0.0011
365 DUODENAL ULCER HAEMORRHAGE 3 0.0010
366 CLAVICLE FRACTURE 4 0.0010
367 NAUSEA 825 0.0010
368 KIDNEY TRANSPLANT REJECTION 5 0.0010
369 DYSPNOEA AT REST 3 0.0010
370 TACHYCARDIA 92 0.0010
371 ENTEROCOCCAL INFECTION 5 0.0010
372 LUMBAR SPINAL STENOSIS 3 0.0010
373 CARDIOPULMONARY FAILURE 4 0.0010
374 BLOOD PRESSURE SYSTOLIC INCREASED 20 0.0010
375 PROCEDURAL HAEMORRHAGE 4 0.0010
376 BLOOD TRIGLYCERIDES INCREASED 18 0.0010
377 LOW BIRTH WEIGHT BABY 8 0.0010
378 BLOOD PRESSURE ABNORMAL 20 0.0010
379 HAEMATOMA 26 0.0010
380 GASTRIC ULCER 19 0.0010
381 DERMATITIS EXFOLIATIVE 5 0.0010
382 CORONARY ARTERY STENOSIS 5 0.0010
383 DUODENAL ULCER 7 0.0010
384 REBOUND ACID HYPERSECRETION 3 0.0010
385 CRANIOCEREBRAL INJURY 3 0.0010
386 SUBARACHNOID HAEMORRHAGE 10 0.0010
387 BRONCHOSPASM 14 0.0010
388 ASPHYXIA 8 0.0010
389 SUBDURAL HAEMATOMA 14 0.0010
390 NEPHROPATHY 9 0.0010
391 HYDRONEPHROSIS 7 0.0009
392 HYPOMAGNESAEMIA 13 0.0009
393 ALTERED STATE OF CONSCIOUSNESS 20 0.0009
394 HEPATITIS ACUTE 6 0.0009
395 HEPATOCELLULAR CARCINOMA 7 0.0009
396 SEPTIC SHOCK 40 0.0009
397 IMMOBILE 4 0.0009
398 HAEMORRHAGIC ANAEMIA 4 0.0009
399 RESPIRATORY RATE INCREASED 8 0.0009
400 SEIZURE 104 0.0009
401 VENTRICULAR FIBRILLATION 10 0.0009
402 ISCHAEMIC STROKE 16 0.0009
403 CARDIOMEGALY 11 0.0009
404 POTENTIATING DRUG INTERACTION 3 0.0009
405 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 23 0.0009
406 PULMONARY ALVEOLAR HAEMORRHAGE 5 0.0009
407 GASTROENTERITIS 13 0.0009
408 DIABETIC RETINOPATHY 3 0.0009
409 ATRIAL FLUTTER 7 0.0009
410 AUTOIMMUNE HAEMOLYTIC ANAEMIA 3 0.0009
411 TRANSPLANT REJECTION 7 0.0009
412 LEFT VENTRICULAR FAILURE 3 0.0009
413 PLEURAL EFFUSION 53 0.0009
414 ERYTHEMA MULTIFORME 8 0.0009
415 THROMBOPHLEBITIS 3 0.0009
416 HEART RATE DECREASED 30 0.0009
417 HAEMORRHAGE SUBCUTANEOUS 3 0.0008
418 FIBRIN D DIMER INCREASED 3 0.0008
419 CARDIAC TAMPONADE 4 0.0008
420 PLATELET COUNT DECREASED 89 0.0008
421 BLOOD PRESSURE INADEQUATELY CONTROLLED 5 0.0008
422 HUMERUS FRACTURE 4 0.0008
423 MEDICATION ERROR 46 0.0008
424 SHOCK 19 0.0008
425 PULMONARY HYPERTENSION 17 0.0008
426 AMYLASE INCREASED 3 0.0008
427 BLOOD PRESSURE DIASTOLIC DECREASED 6 0.0008
428 LIP SWELLING 27 0.0008
429 PYELONEPHRITIS 7 0.0008
430 HYPOAESTHESIA ORAL 12 0.0008
431 RESTLESSNESS 29 0.0008
432 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 4 0.0008
433 TROPONIN INCREASED 6 0.0008
434 TOE AMPUTATION 4 0.0008
435 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 3 0.0008
436 ACIDOSIS 6 0.0008
437 OCCUPATIONAL EXPOSURE TO PRODUCT 5 0.0008
438 ANAPHYLACTIC SHOCK 20 0.0008
439 OPTIC ISCHAEMIC NEUROPATHY 3 0.0008
440 PERIORBITAL OEDEMA 4 0.0008
441 GASTROINTESTINAL HAEMORRHAGE 64 0.0008
442 VENOUS THROMBOSIS 3 0.0008
443 BRAIN NEOPLASM 7 0.0008
444 ARTERIOSCLEROSIS CORONARY ARTERY 5 0.0008
445 HAEMATEMESIS 19 0.0007
446 INTRACRANIAL ANEURYSM 3 0.0007
447 OEDEMA 40 0.0007
448 PERICARDIAL EFFUSION 17 0.0007
449 ANAPHYLACTOID REACTION 3 0.0007
450 INTESTINAL ISCHAEMIA 4 0.0007
451 GASTROINTESTINAL PERFORATION 3 0.0007
452 MALNUTRITION 8 0.0007
453 RESPIRATORY FAILURE 52 0.0007
454 LYMPHOPENIA 10 0.0007
455 PNEUMONIA 228 0.0007
456 ABSCESS LIMB 3 0.0007
457 INTERNATIONAL NORMALISED RATIO INCREASED 20 0.0007
458 CORONARY ARTERY BYPASS 4 0.0007
459 PREMATURE DELIVERY 11 0.0007
460 DERMATITIS BULLOUS 5 0.0007
461 PERITONEAL DIALYSIS COMPLICATION 5 0.0007
462 PULMONARY CONGESTION 9 0.0007
463 LUNG INFILTRATION 6 0.0007
464 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 6 0.0007
465 LOWER GASTROINTESTINAL HAEMORRHAGE 5 0.0007
466 ACUTE RESPIRATORY FAILURE 13 0.0007
467 HAEMOLYTIC ANAEMIA 6 0.0007
468 HYPERSENSITIVITY 124 0.0007
469 HEPATITIS CHOLESTATIC 4 0.0007
470 PEMPHIGOID 5 0.0007
471 CYTOMEGALOVIRUS INFECTION 11 0.0007
472 CONTRAINDICATED PRODUCT ADMINISTERED 20 0.0007
473 HYPOGLYCAEMIA 32 0.0007
474 INGUINAL HERNIA 4 0.0007
475 PROCEDURAL COMPLICATION 5 0.0007
476 PHARYNGEAL OEDEMA 10 0.0006
477 SMALL INTESTINAL OBSTRUCTION 8 0.0006
478 ATRIOVENTRICULAR BLOCK 5 0.0006
479 BLOOD ALKALINE PHOSPHATASE INCREASED 16 0.0006
480 UMBILICAL HERNIA 3 0.0006
481 FLANK PAIN 6 0.0006
482 TIBIA FRACTURE 3 0.0006
483 DISSEMINATED INTRAVASCULAR COAGULATION 9 0.0006
484 ARTERIOSCLEROSIS 6 0.0006
485 RASH 276 0.0006
486 GAMMA-GLUTAMYLTRANSFERASE INCREASED 14 0.0006
487 RENAL CYST 5 0.0006
488 SCREAMING 4 0.0006
489 SUBCUTANEOUS ABSCESS 3 0.0006
490 CARDIAC FAILURE CONGESTIVE 50 0.0006
491 INCOHERENT 4 0.0006
492 DRUG SPECIFIC ANTIBODY PRESENT 4 0.0006
493 RENAL CELL CARCINOMA 3 0.0006
494 HEPARIN-INDUCED THROMBOCYTOPENIA 3 0.0006
495 ORGANISING PNEUMONIA 3 0.0006
496 EMBOLISM 5 0.0006
497 HYPERNATRAEMIA 3 0.0006
498 MULTIPLE ORGAN DYSFUNCTION SYNDROME 17 0.0006
499 HYPERAMMONAEMIA 3 0.0006
500 BRAIN INJURY 6 0.0006
501 PNEUMOCYSTIS JIROVECII PNEUMONIA 6 0.0006
502 DIZZINESS 298 0.0006
503 GLYCOSYLATED HAEMOGLOBIN INCREASED 15 0.0006
504 KLEBSIELLA INFECTION 3 0.0006
505 DYSLIPIDAEMIA 3 0.0006
506 GENERAL PHYSICAL HEALTH DETERIORATION 68 0.0006
507 CHOLECYSTITIS 7 0.0006
508 MUSCLE RIGIDITY 7 0.0006
509 CACHEXIA 3 0.0006
510 DEPRESSED LEVEL OF CONSCIOUSNESS 23 0.0006
511 RESPIRATION ABNORMAL 4 0.0006
512 CARDIAC MURMUR 5 0.0006
513 SWOLLEN TONGUE 18 0.0006
514 URINE OUTPUT DECREASED 5 0.0006
515 BLOOD CALCIUM INCREASED 5 0.0006
516 MALAISE 248 0.0006
517 ANGIOEDEMA 25 0.0006
518 DIABETES MELLITUS INADEQUATE CONTROL 10 0.0006
519 ILEUS 7 0.0006
520 DIVERTICULUM 4 0.0006
521 PANCYTOPENIA 31 0.0006
522 FAECES DISCOLOURED 12 0.0006
523 OSTEOMYELITIS 10 0.0006
524 HYPOPHOSPHATAEMIA 4 0.0005
525 HEPATIC FUNCTION ABNORMAL 20 0.0005
526 HEPATIC ENCEPHALOPATHY 5 0.0005
527 ANGIOPATHY 3 0.0005
528 OXYGEN SATURATION DECREASED 30 0.0005
529 FACE OEDEMA 9 0.0005
530 TRANSIENT ISCHAEMIC ATTACK 18 0.0005
531 ABDOMINAL PAIN 124 0.0005
532 SYNCOPE 53 0.0005
533 CHOLECYSTITIS ACUTE 3 0.0005
534 AORTIC ANEURYSM 4 0.0005
535 NEOPLASM 6 0.0005
536 WHITE BLOOD CELL COUNT INCREASED 20 0.0005
537 FEMUR FRACTURE 16 0.0005
538 RALES 3 0.0005
539 RETCHING 11 0.0005
540 MYOCARDIAL INFARCTION 90 0.0005
541 APHTHOUS ULCER 4 0.0005
542 SKIN WARM 3 0.0005
543 RENAL DISORDER 24 0.0005
544 LUNG INFECTION 8 0.0005
545 TACHYPNOEA 7 0.0005
546 SYRINGE ISSUE 9 0.0005
547 PELVIC FRACTURE 4 0.0005
548 GASTRIC CANCER 13 0.0005
549 PHARYNGEAL SWELLING 5 0.0005
550 HEAD INJURY 16 0.0005
551 HALLUCINATION, AUDITORY 8 0.0005
552 ELECTROCARDIOGRAM QT PROLONGED 18 0.0005
553 INFECTION 72 0.0005
554 PALPITATIONS 58 0.0005
555 HYPOTHERMIA 5 0.0005
556 HEPATOCELLULAR INJURY 7 0.0005
557 PRESYNCOPE 12 0.0005
558 FOETAL GROWTH RESTRICTION 3 0.0005
559 CARDIAC DISORDER 46 0.0005
560 PANCREATITIS ACUTE 11 0.0005
561 EAR DISCOMFORT 5 0.0005
562 GENERALISED OEDEMA 6 0.0005
563 CHOLANGITIS 3 0.0005
564 HYPERBILIRUBINAEMIA 5 0.0005
565 ATRIAL FIBRILLATION 47 0.0005
566 VENTRICULAR EXTRASYSTOLES 5 0.0005
567 HEMIPLEGIA 4 0.0005
568 DISORIENTATION 19 0.0005
569 HEPATIC CIRRHOSIS 9 0.0005
570 SWELLING 44 0.0005
571 LETHARGY 27 0.0005
572 HAEMORRHAGE 49 0.0005
573 PSEUDOMONAS INFECTION 4 0.0005
574 ANURIA 4 0.0005
575 ACUTE KIDNEY INJURY 71 0.0005
576 CORONARY ARTERY DISEASE 14 0.0005
577 REFUSAL OF TREATMENT BY PATIENT 3 0.0005
578 ECZEMA 24 0.0005
579 BLOOD PRESSURE FLUCTUATION 11 0.0005
580 LOCALISED INFECTION 11 0.0005
581 APPETITE DISORDER 3 0.0005
582 PRESCRIBED UNDERDOSE 9 0.0005
583 PANCREATIC CARCINOMA 13 0.0004
584 SKIN MASS 3 0.0004
585 TERMINAL STATE 3 0.0004
586 THROMBOCYTOPENIA 50 0.0004
587 METASTASES TO LYMPH NODES 3 0.0004
588 POSTOPERATIVE WOUND INFECTION 3 0.0004
589 FEEDING DISORDER 9 0.0004
590 DISCOMFORT 27 0.0004
591 GENERAL PHYSICAL CONDITION ABNORMAL 3 0.0004
592 PULMONARY EMBOLISM 42 0.0004
593 DISEASE PROGRESSION 52 0.0004
594 MATERNAL EXPOSURE BEFORE PREGNANCY 3 0.0004
595 ACUTE HEPATIC FAILURE 6 0.0004
596 ABDOMINAL HERNIA 2 0.0004
597 CEREBROVASCULAR ACCIDENT 74 0.0004
598 CELLULITIS 22 0.0004
599 HIP FRACTURE 14 0.0004
600 HYPOKALAEMIA 20 0.0004
601 CARDIOVASCULAR DISORDER 11 0.0004
602 METASTASES TO LUNG 5 0.0004
603 FORMICATION 3 0.0004
604 AGRANULOCYTOSIS 8 0.0004
605 ELECTROLYTE IMBALANCE 5 0.0004
606 DEMENTIA 12 0.0004
607 APPENDICITIS 4 0.0004
608 SKIN ULCER 11 0.0004
609 VENTRICULAR TACHYCARDIA 7 0.0004
610 GENERALISED TONIC-CLONIC SEIZURE 7 0.0004
611 METASTASIS 3 0.0004
612 NEOPLASM MALIGNANT 28 0.0004
613 CARDIOGENIC SHOCK 6 0.0004
614 CHOLESTASIS 8 0.0004
615 PARAESTHESIA ORAL 6 0.0004
616 PANIC REACTION 3 0.0004
617 SWELLING FACE 27 0.0004
618 ATELECTASIS 4 0.0004
619 FAECES SOFT 3 0.0004
620 THROMBOTIC MICROANGIOPATHY 4 0.0004
621 CHOKING 8 0.0004
622 METABOLIC ACIDOSIS 13 0.0004
623 MEDICAL DEVICE COMPLICATION 3 0.0004
624 CEREBRAL DISORDER 3 0.0004
625 STEVENS-JOHNSON SYNDROME 9 0.0004
626 PHARYNGITIS 5 0.0004
627 ORTHOSTATIC HYPOTENSION 7 0.0004
628 ANEURYSM 2 0.0004
629 RESPIRATORY DISORDER 12 0.0004
630 TOXIC EPIDERMAL NECROLYSIS 6 0.0004
631 STAPHYLOCOCCAL INFECTION 13 0.0004
632 MOTOR DYSFUNCTION 4 0.0004
633 AMMONIA INCREASED 2 0.0004
634 CHILLS 45 0.0004
635 PLATELET COUNT INCREASED 5 0.0004
636 PETECHIAE 4 0.0004
637 HEADACHE 240 0.0004
638 HAEMATURIA 13 0.0004
639 THERAPEUTIC RESPONSE DECREASED 23 0.0004
640 SCRATCH 4 0.0004
641 NEEDLE ISSUE 11 0.0004
642 FALL 125 0.0004
643 BACTERIAL INFECTION 7 0.0004
644 ASTHENIA 141 0.0004
645 ANAL FISSURE 2 0.0004
646 FEELING JITTERY 7 0.0004
647 FEELING ABNORMAL 88 0.0004
648 IMPAIRED GASTRIC EMPTYING 5 0.0004
649 WOUND INFECTION 4 0.0004
650 ASPIRATION 4 0.0004
651 ESCHERICHIA INFECTION 3 0.0004
652 HAEMATOCHEZIA 20 0.0004
653 RASH MACULO-PAPULAR 8 0.0004
654 HAEMORRHOIDS 7 0.0004
655 BRADYCARDIA 19 0.0004
656 THROAT IRRITATION 16 0.0004
657 INTESTINAL PERFORATION 4 0.0004
658 THERAPY NON-RESPONDER 16 0.0004
659 DIABETES MELLITUS 27 0.0004
660 HEART RATE IRREGULAR 8 0.0004
661 INFLAMMATION 18 0.0003
662 EPISTAXIS 26 0.0003
663 RASH GENERALISED 9 0.0003
664 MUSCLE TWITCHING 8 0.0003
665 SPEECH DISORDER 18 0.0003
666 VASCULITIS 4 0.0003
667 BODY TEMPERATURE INCREASED 7 0.0003
668 GASTRITIS 9 0.0003
669 ASCITES 10 0.0003
670 LIVER DISORDER 15 0.0003
671 PYREXIA 117 0.0003
672 IMMUNODEFICIENCY 5 0.0003
673 VISION BLURRED 46 0.0003
674 ACCIDENT 4 0.0003
675 GASTROINTESTINAL INFECTION 3 0.0003
676 HAEMORRHAGE INTRACRANIAL 5 0.0003
677 PLASMA CELL MYELOMA 13 0.0003
678 HEPATIC CANCER 8 0.0003
679 BLOOD POTASSIUM DECREASED 10 0.0003
680 OROPHARYNGEAL DISCOMFORT 3 0.0003
681 HOSPITALISATION 51 0.0003
682 HOT FLUSH 25 0.0003
683 HEPATIC FAILURE 10 0.0003
684 RENAL FAILURE ACUTE 14 0.0003
685 EATING DISORDER 7 0.0003
686 NO THERAPEUTIC RESPONSE 4 0.0003
687 ENCEPHALOPATHY 8 0.0003
688 MENTAL STATUS CHANGES 9 0.0003
689 FEELING COLD 9 0.0003
690 MUSCULOSKELETAL CHEST PAIN 5 0.0003
691 ANKLE FRACTURE 5 0.0003
692 URINARY TRACT INFECTION 55 0.0003
693 DYSKINESIA 13 0.0003
694 DYSARTHRIA 12 0.0003
695 DECREASED APPETITE 74 0.0003
696 DERMATITIS ALLERGIC 4 0.0003
697 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 3 0.0003
698 BURNING SENSATION 22 0.0003
699 ABSCESS 5 0.0003
700 HYPOPHAGIA 8 0.0003
701 ROAD TRAFFIC ACCIDENT 13 0.0003
702 VITAMIN D DEFICIENCY 3 0.0003
703 RESPIRATORY TRACT INFECTION 8 0.0003
704 RENAL TUBULAR NECROSIS 3 0.0003
705 HEPATOMEGALY 3 0.0003
706 PARAESTHESIA 48 0.0003
707 THERAPY CHANGE 3 0.0003
708 LIGAMENT SPRAIN 3 0.0003
709 RENAL INJURY 9 0.0003
710 BLISTER 17 0.0003
711 HYPERGLYCAEMIA 11 0.0003
712 LEUKOPENIA 15 0.0003
713 COUGH 84 0.0003
714 PREMATURE BABY 9 0.0003
715 CANDIDA INFECTION 5 0.0003
716 TASTE DISORDER 6 0.0003
717 EPILEPSY 9 0.0003
718 GINGIVAL BLEEDING 4 0.0003
719 DEEP VEIN THROMBOSIS 19 0.0003
720 CORONARY ARTERY OCCLUSION 4 0.0003
721 BONE PAIN 17 0.0003
722 DIARRHOEA 186 0.0003
723 COORDINATION ABNORMAL 4 0.0003
724 WHEEZING 17 0.0003
725 TRANSFUSION 3 0.0003
726 DEHYDRATION 38 0.0003
727 BLOOD TEST ABNORMAL 4 0.0003
728 DEVICE OCCLUSION 4 0.0003
729 CLOSTRIDIUM DIFFICILE COLITIS 3 0.0003
730 PULMONARY ARTERIAL HYPERTENSION 4 0.0003
731 INJECTION SITE HAEMATOMA 4 0.0003
732 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
733 PRODUCT STORAGE ERROR 24 0.0003
734 TREMOR 45 0.0003
735 ANXIETY 77 0.0003
736 SNEEZING 6 0.0003
737 HYPOAESTHESIA 40 0.0003
738 FISTULA 3 0.0003
739 INTESTINAL OBSTRUCTION 10 0.0003
740 BLOOD COUNT ABNORMAL 4 0.0003
741 SCAB 3 0.0003
742 GASTRIC HAEMORRHAGE 3 0.0003
743 DRUG ADMINISTRATION ERROR 8 0.0003
744 POST PROCEDURAL COMPLICATION 5 0.0003
745 CONFUSIONAL STATE 42 0.0003
746 PAIN 159 0.0003
747 WHITE BLOOD CELL COUNT DECREASED 28 0.0003
748 LIMB INJURY 7 0.0003
749 BRONCHITIS 19 0.0003
750 DRUG-INDUCED LIVER INJURY 8 0.0003
751 COVID-19 PNEUMONIA 3 0.0003
752 DIVERTICULITIS 7 0.0003
753 ULCER 4 0.0003
754 HAEMOPTYSIS 7 0.0003
755 SCIATICA 4 0.0003
756 HYPOTHYROIDISM 8 0.0003
757 MUSCLE TIGHTNESS 4 0.0002
758 LUNG NEOPLASM MALIGNANT 10 0.0002
759 RIB FRACTURE 5 0.0002
760 ILLNESS 25 0.0002
761 OSTEONECROSIS OF JAW 6 0.0002
762 LOWER RESPIRATORY TRACT INFECTION 11 0.0002
763 FEBRILE NEUTROPENIA 16 0.0002
764 PERICARDITIS 4 0.0002
765 OEDEMA PERIPHERAL 29 0.0002
766 MUSCULAR WEAKNESS 27 0.0002
767 URINARY INCONTINENCE 7 0.0002
768 FLUID RETENTION 12 0.0002
769 BLOOD GLUCOSE INCREASED 44 0.0002
770 ABDOMINAL DISCOMFORT 39 0.0002
771 MUSCULOSKELETAL DISCOMFORT 4 0.0002
772 HIATUS HERNIA 3 0.0002
773 BEDRIDDEN 3 0.0002
774 ORAL CANDIDIASIS 3 0.0002
775 METASTASES TO LIVER 4 0.0002
776 INTERSTITIAL LUNG DISEASE 11 0.0002
777 ADVERSE REACTION 3 0.0002
778 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
779 EYE HAEMORRHAGE 3 0.0002
780 GALLBLADDER DISORDER 4 0.0002
781 THIRST 4 0.0002
782 THROMBOSIS 18 0.0002
783 UVEITIS 3 0.0002
784 TREATMENT NONCOMPLIANCE 12 0.0002
785 SKIN LESION 6 0.0002
786 PROSTATIC SPECIFIC ANTIGEN INCREASED 3 0.0002
787 ILL-DEFINED DISORDER 13 0.0002
788 TUBULOINTERSTITIAL NEPHRITIS 4 0.0002
789 MATERNAL EXPOSURE DURING PREGNANCY 19 0.0002
790 RENAL CANCER 10 0.0002
791 CONVULSION 12 0.0002
792 RECTAL HAEMORRHAGE 9 0.0002
793 ABDOMINAL PAIN UPPER 43 0.0002
794 BLOOD CREATINE PHOSPHOKINASE INCREASED 6 0.0002
795 HYPERTHYROIDISM 3 0.0002
796 LUNG DISORDER 10 0.0002
797 KIDNEY INFECTION 4 0.0002
798 LABORATORY TEST ABNORMAL 6 0.0002
799 CATARACT 12 0.0002
800 APHASIA 6 0.0002
801 PRODUCT ADMINISTRATION ERROR 4 0.0002
802 LYMPHADENOPATHY 7 0.0002
803 CONTUSION 19 0.0002
804 INFLUENZA 22 0.0002
805 SYSTEMIC LUPUS ERYTHEMATOSUS 7 0.0002
806 TINNITUS 9 0.0002
807 HYPONATRAEMIA 11 0.0002
808 THERAPY CESSATION 10 0.0002
809 DRUG RESISTANCE 5 0.0002
810 LYMPHOMA 3 0.0002
811 MUSCLE SPASMS 35 0.0002
812 SICKLE CELL ANAEMIA WITH CRISIS 3 0.0002
813 DYSURIA 7 0.0002
814 HALLUCINATION, VISUAL 4 0.0002
815 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
816 CYSTITIS 6 0.0002
817 DYSPHONIA 11 0.0002
818 SENSORY DISTURBANCE 3 0.0002
819 PRODUCT PRESCRIBING ISSUE 4 0.0002
820 CHOLELITHIASIS 6 0.0002
821 METASTASES TO BONE 3 0.0002
822 MUSCULOSKELETAL STIFFNESS 16 0.0002
823 COAGULOPATHY 3 0.0002
824 URINARY RETENTION 6 0.0002
825 WOUND 5 0.0002
826 HEMIPARESIS 3 0.0002
827 MYALGIA 30 0.0002
828 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
829 ABORTION SPONTANEOUS 7 0.0002
830 SKIN DISCOLOURATION 8 0.0002
831 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 9 0.0002
832 DRY SKIN 23 0.0002
833 NERVOUSNESS 9 0.0002
834 BLINDNESS 7 0.0002
835 NEUTROPHIL COUNT DECREASED 7 0.0002
836 CONDITION AGGRAVATED 52 0.0002
837 DRUG INTERACTION 27 0.0002
838 OSTEOPOROSIS 7 0.0002
839 GOUT 3 0.0002
840 FATIGUE 130 0.0002
841 RASH PRURITIC 9 0.0002
842 INFUSION RELATED REACTION 11 0.0002
843 LEUKOCYTOSIS 3 0.0002
844 BONE DISORDER 3 0.0002
845 EYE SWELLING 6 0.0002
846 HEPATIC STEATOSIS 3 0.0002
847 DYSPHAGIA 15 0.0002
848 PRODUCT COMPLAINT 4 0.0002
849 PROTEINURIA 3 0.0002
850 NEUTROPENIA 21 0.0002
851 OFF LABEL USE 134 0.0002
852 MENORRHAGIA 3 0.0002
853 PAIN IN EXTREMITY 45 0.0002
854 ANHEDONIA 4 0.0002
855 VIRAL INFECTION 5 0.0002
856 SPINAL FRACTURE 3 0.0001
857 PERIPHERAL SWELLING 23 0.0001
858 PRODUCT USE ISSUE 28 0.0001
859 EYE PRURITUS 5 0.0001
860 OVERDOSE 32 0.0001
861 COVID-19 26 0.0001
862 FOETAL EXPOSURE DURING PREGNANCY 12 0.0001
863 NEUROPATHY PERIPHERAL 14 0.0001
864 BLOOD GLUCOSE DECREASED 7 0.0001
865 DELIRIUM 5 0.0001
866 NECK PAIN 8 0.0001
867 LIVER FUNCTION TEST INCREASED 3 0.0001
868 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
869 PRODUCT DOSE OMISSION 9 0.0001
870 LIVER FUNCTION TEST ABNORMAL 4 0.0001
871 UNDERDOSE 10 0.0001
872 BLADDER CANCER 8 0.0001
873 TRANSAMINASES INCREASED 3 0.0001
874 LACRIMATION INCREASED 4 0.0001
875 UNEVALUABLE EVENT 10 0.0001
876 PRODUCT AVAILABILITY ISSUE 3 0.0001
877 EXPOSURE DURING PREGNANCY 8 0.0001
878 COMA 6 0.0001
879 RASH ERYTHEMATOUS 6 0.0001
880 MOBILITY DECREASED 9 0.0001
881 MOVEMENT DISORDER 4 0.0001
882 SOMNOLENCE 25 0.0001
883 LACTIC ACIDOSIS 4 0.0001
884 GASTROINTESTINAL DISORDER 11 0.0001
885 HERPES ZOSTER 7 0.0001
886 EYE DISORDER 4 0.0001
887 RHABDOMYOLYSIS 5 0.0001
888 HALLUCINATION 9 0.0001
889 ABDOMINAL PAIN LOWER 3 0.0001
890 EXPOSURE VIA SKIN CONTACT 3 0.0001
891 DEVICE DISLOCATION 5 0.0001
892 DEAFNESS 3 0.0001
893 CONSTIPATION 25 0.0001
894 INTENTIONAL PRODUCT USE ISSUE 10 0.0001
895 DEPRESSED MOOD 6 0.0001
896 PROSTATE CANCER 9 0.0001
897 GASTROOESOPHAGEAL REFLUX DISEASE 9 0.0001
898 JAUNDICE 3 0.0001
899 DRUG EFFECT DECREASED 6 0.0001
900 ADVERSE DRUG REACTION 10 0.0001
901 MOOD ALTERED 3 0.0001
902 GAIT DISTURBANCE 21 0.0001
903 ADVERSE EVENT 10 0.0001
904 PROCEDURAL PAIN 3 0.0001
905 BLOOD CHOLESTEROL INCREASED 5 0.0001
906 DYSPNOEA EXERTIONAL 4 0.0001
907 OCULAR HYPERAEMIA 5 0.0001
908 INTENTIONAL DOSE OMISSION 3 0.0001
909 HYPERSOMNIA 3 0.0001
910 NASOPHARYNGITIS 19 0.0001
911 DYSSTASIA 3 0.0001
912 PSYCHOTIC DISORDER 3 0.0001
913 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
914 ALANINE AMINOTRANSFERASE INCREASED 6 0.0001
915 INFLUENZA LIKE ILLNESS 8 0.0001
916 DRUG DOSE OMISSION 16 0.0001
917 ABDOMINAL DISTENSION 10 0.0001
918 BONE DENSITY DECREASED 3 0.0001
919 OSTEOARTHRITIS 4 0.0001
920 ASPARTATE AMINOTRANSFERASE INCREASED 5 0.0001
921 BALANCE DISORDER 8 0.0001
922 VAGINAL HAEMORRHAGE 4 0.0001
923 MENTAL DISORDER 4 0.0001
924 DRUG INEFFECTIVE 121 0.0001
925 IMPAIRED HEALING 3 0.0001
926 OSTEONECROSIS 3 0.0001
927 VISUAL ACUITY REDUCED 3 0.0001
928 SKIN DISORDER 3 0.0001
929 GAIT INABILITY 3 0.0001
930 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
931 DEVICE ISSUE 8 0.0001
932 ARTHRALGIA 37 0.0001
933 PRODUCT USE IN UNAPPROVED INDICATION 22 0.0001
934 VISUAL IMPAIRMENT 11 0.0001
935 EYE PAIN 5 0.0001
936 FLATULENCE 5 0.0001
937 NEPHROLITHIASIS 4 0.0001
938 RASH MACULAR 3 0.0001
939 SURGERY 5 0.0001
940 HYPOXIA 3 0.0001
941 MIGRAINE 8 0.0001
942 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4 0.0001
943 DRUG INTOLERANCE 8 0.0001
944 DRUG EFFECT INCOMPLETE 3 0.0001
945 WEIGHT DECREASED 23 0.0001
946 AGITATION 6 0.0001
947 ABASIA 2 0.0001
948 DYSGEUSIA 6 0.0001
949 MEMORY IMPAIRMENT 11 0.0001
950 MUSCULOSKELETAL PAIN 4 0.0001
951 BREAST CANCER 7 0.0001
952 DYSPEPSIA 7 0.0001
953 THERAPY INTERRUPTED 5 0.0001
954 PRODUCT QUALITY ISSUE 9 0.0001
955 STOMATITIS 4 0.0001
956 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
957 OROPHARYNGEAL PAIN 6 0.0001
958 COGNITIVE DISORDER 3 0.0001
959 PRODUCTIVE COUGH 3 0.0001
960 WEIGHT INCREASED 14 0.0001
961 AMNESIA 4 0.0001
962 INJECTION SITE PRURITUS 4 0.0001
963 SKIN EXFOLIATION 5 0.0001
964 ANGER 2 0.0001
965 HEPATIC ENZYME INCREASED 4 0.0001
966 MALIGNANT NEOPLASM PROGRESSION 6 0.0001
967 EMOTIONAL DISTRESS 7 0.0001
968 INTENTIONAL PRODUCT MISUSE 5 0.0001
969 PANCREATITIS 3 0.0001
970 ACCIDENTAL OVERDOSE 2 0.0001
971 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 11 0.0001
972 ASTHMA 6 0.0001
973 RHEUMATOID ARTHRITIS 6 0.0001
974 NASAL CONGESTION 3 0.0001
975 ALOPECIA 10 0.0001
976 ARTHRITIS 4 0.0001
977 ABNORMAL BEHAVIOUR 2 0.0001
978 INJECTION SITE BRUISING 4 0.0001
979 VERTIGO 3 0.0000
980 INSOMNIA 13 0.0000
981 SINUSITIS 5 0.0000
982 INCORRECT DOSE ADMINISTERED 11 0.0000
983 INTENTIONAL OVERDOSE 3 0.0000
984 PRODUCT DOSE OMISSION ISSUE 13 0.0000
985 SLEEP DISORDER 3 0.0000
986 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
987 DEPRESSION 9 0.0000
988 DRY MOUTH 3 0.0000
989 TREATMENT FAILURE 3 0.0000
990 PSORIASIS 3 0.0000
991 INJECTION SITE PAIN 5 0.0000